ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00327262
Recruitment Status : Unknown
Verified September 2005 by Central European Leukemia Study Group.
Recruitment status was:  Recruiting
First Posted : May 18, 2006
Last Update Posted : June 20, 2006
Sponsor:
Information provided by:
Central European Leukemia Study Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : December 2008
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):